About COMPARATIVE BIOSCIENCES, INC.
Comparative Biosciences, Inc. (CBI) is a preclinical research organization specializing in drug discovery and development, offering services in toxicology, pharmacokinetics, histopathology, and disease modeling across multiple therapeutic areas. CBI is part of Genesis Drug Discovery & Development (GD3), a fully integrated CRO.
Toxicology in preclinical studiesDermal and ocular toxicologyPharmacokinetics (dermal, ocular, and preclinical)Histopathology and immunohistochemistryDisease modeling (dermatology, ophthalmology, cardiovascular, oncology, etc.)Surgical modeling and intraocular lens implantationCannabis pharmacologyStem cell research
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to COMPARATIVE BIOSCIENCES, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.